Subscribe

ICON Public Limited Company (ICLR)

USD166.10 -1.62 (-0.97%)
IE NASDAQ Healthcare Medical - Diagnostics & Research
Address South County Business Park D18 X5R3
Dublin, IE
CEO Barry Balfe
IPO 1998-05-15
CIK 1060955 ISIN IE0005711209

Explore sections of this company profile

Description

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD166.10 -1.62 (-0.97%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.27
Float Shares
75.95M
Free Float %
99.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+15.49% +17.35% +33.48% +26.50% -26.05% -24.93% +4.56% -34.38% -38.86% +94.21% +2,051.15%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (30 ratings, all time) Buy
Price Targets & DCF
Current price
166.10
Low 100.00 -39.8%
Consensus 146.50 -11.8%
Median 129.00 -22.3%
High 222.00 +33.7%
DCF (Unlevered) 299.50 +80.3%
DCF (Levered) 176.94 +6.5%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 50% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 8 +1
Hold 8 +1
Sell 0 0
Strong Sell 1 0
Price Target Summary
Period # Analysts Avg Target
Last Month 4
124.50
-25.0%
Last Quarter 4
124.50
-25.0%
Last Year 19
166.37
+0.2%
All Time 34
235.94
+42.0%
Quality scores
Altman Z-Score
1.69
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
6 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Diagnostics & Research: +7.9%
    -0.4% Q1'26: +1.6% (vs Q1'25)
  • EPS growth Medical - Diagnostics & Research: +30.8%
    -69.6% Q1'26: -28.4% (vs Q1'25)
  • FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%
    +4.1% Q1'26: +30.6% (vs Q1'25)
  • EBIT margin Medical - Diagnostics & Research: +9.6%
    +5.3% Q1'26: +8.5% (vs Q1'25)
  • ROIC Medical - Diagnostics & Research: +5.2%
    +3.3% Q1'26: +4.7% (vs Q1'25)
  • Share dilution Medical - Diagnostics & Research: 0.0%
    -4.9% Q1'26: -6.0% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×
    4.32× Q1'26: 3.37× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.23) × ERP
WACC = 75% × Ke + 25% × Kd (5.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 213.16 Current price: 166.10
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 1999
actual
Dec 2000
actual
Dec 2001
actual
Dec 2002
actual
Dec 2003
actual
Dec 2004
actual
Dec 2006
actual
Dec 2007
actual
Dec 2008
actual
Dec 2009
actual
Dec 2010
actual
Dec 2011
actual
Dec 2012
actual
Dec 2013
actual
Dec 2014
actual
Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
11 Rev. Ana.
10 EPS Ana.
Dec 2027
11 Rev. Ana.
10 EPS Ana.
Dec 2028
11 Rev. Ana.
6 EPS Ana.
Dec 2029
5 Rev. Ana.
4 EPS Ana.
Dec 2030
5 Rev. Ana.
2 EPS Ana.
Revenue
55.80M
est: 60.42M (-7.7%)
80.77M
est: 98.02M (-17.6%)
116.16M
est: 135.20M (-14.1%)
156.56M
est: 175.83M (-11.0%)
225.73M
est: 253.91M (-11.1%)
296.92M
est: 306.11M (-3.0%)
455.60M
est: 418.82M (+8.8%)
630.72M
est: 588.24M (+7.2%)
865.25M
est: 815.08M (+6.2%)
887.61M
est: 804.39M (+10.3%)
900.04M
est: 918.39M (-2.0%)
945.73M
est: 1.03B (-8.6%)
1.12B
est: 1.10B (+1.6%)
1.34B
est: 1.19B (+12.7%)
1.50B
est: 1.32B (+13.5%)
1.57B
est: 1.58B (-0.4%)
1.67B
est: 1.67B (-0.3%)
1.76B
est: 1.76B (+0.0%)
2.60B
est: 2.59B (+0.1%)
2.81B
est: 2.81B (-0.2%)
2.80B
est: 2.79B (+0.3%)
5.48B
est: 5.49B (-0.2%)
7.74B
est: 7.74B (0.0%)
8.12B
est: 8.33B (-2.5%)
8.28B
est: 8.28B (+0.0%)
8.25B
est: 8.03B (+2.7%)
8.02B
7.94B – 8.06B
-0.2% YoY
8.20B
8.15B – 8.25B
+2.3% YoY
8.58B
8.57B – 8.59B
+4.6% YoY
9.04B
8.95B – 9.13B
+5.4% YoY
9.48B
9.38B – 9.58B
+4.8% YoY
EBITDA
9.01M
est: 7.64M (+17.9%)
11.38M
est: 14.85M (-23.4%)
16.05M
est: 22.11M (-27.4%)
24.23M
est: 27.14M (-10.7%)
32.23M
est: 37.16M (-13.3%)
45.55M
est: 45.91M (-0.8%)
62.77M
est: 60.57M (+3.6%)
88.25M
est: 84.70M (+4.2%)
130.11M
est: 118.48M (+9.8%)
140.86M
est: 127.64M (+10.4%)
127.73M
est: 129.70M (-1.5%)
69.32M
est: 74.92M (-7.5%)
111.09M
est: 109.56M (+1.4%)
168.67M
est: 148.20M (+13.8%)
263.69M
est: 223.04M (+18.2%)
339.21M
est: 325.33M (+4.3%)
379.43M
est: 371.28M (+2.2%)
401.94M
est: 388.42M (+3.5%)
451.76M
est: 440.65M (+2.5%)
532.19M
est: 496.80M (+7.1%)
488.83M
est: 484.48M (+0.9%)
739.43M
est: 676.35M (+9.3%)
1.41B
est: 1.08B (+30.7%)
1.52B
est: 1.32B (+15.1%)
1.56B
est: 1.31B (+19.0%)
823.57M
est: 1.27B (-35.4%)
1.27B
1.26B – 1.28B
-0.2% YoY
1.30B
1.29B – 1.31B
+2.3% YoY
1.36B
1.36B – 1.36B
+4.6% YoY
1.43B
1.42B – 1.45B
+5.4% YoY
1.50B
1.49B – 1.52B
+4.8% YoY
EBIT
6.98M
est: -9.38M (+174.4%)
8.15M
est: 9.57M (-14.9%)
11.08M
est: 12.32M (-10.1%)
18.21M
est: 20.50M (-11.1%)
24.93M
est: 27.92M (-10.7%)
34.38M
est: 34.09M (+0.9%)
47.82M
est: 43.92M (+8.9%)
69.24M
est: -258.48M (+126.8%)
102.39M
est: 93.70M (+9.3%)
108.20M
est: 97.33M (+11.2%)
93.86M
est: 93.31M (+0.6%)
30.64M
est: 31.26M (-2.0%)
68.27M
est: 66.23M (+3.1%)
122.15M
est: 106.24M (+15.0%)
211.15M
est: 176.22M (+19.8%)
281.54M
est: 269.04M (+4.6%)
319.85M
est: 310.36M (+3.1%)
340.68M
est: 333.83M (+2.1%)
378.12M
est: 370.42M (+2.1%)
440.27M
est: 430.86M (+2.2%)
394.22M
est: 311.44M (+26.6%)
379.10M
est: 371.35M (+2.1%)
797.58M
est: 550.88M (+44.8%)
935.49M
est: 784.28M (+19.3%)
1.08B
est: 779.30M (+38.0%)
440.57M
est: 756.29M (-41.7%)
754.83M
747.29M – 758.60M
-0.2% YoY
772.02M
767.30M – 776.75M
+2.3% YoY
807.71M
807.01M – 808.41M
+4.6% YoY
851.06M
842.40M – 859.82M
+5.4% YoY
892.11M
883.03M – 901.29M
+4.8% YoY
Net Income
8.05M
est: 5.61M (+43.6%)
6.07M
est: 7.50M (-19.1%)
10.98M
est: 12.70M (-13.6%)
14.20M
est: 15.26M (-6.9%)
18.28M
est: 20.71M (-11.7%)
25.74M
est: 26.42M (-2.6%)
38.30M
est: 35.11M (+9.1%)
55.96M
est: 52.25M (+7.1%)
78.12M
est: 73.55M (+6.2%)
94.30M
est: 85.65M (+10.1%)
87.07M
est: 88.63M (-1.8%)
22.88M
est: 24.04M (-4.8%)
55.42M
est: 53.83M (+3.0%)
102.81M
est: 90.06M (+14.2%)
172.47M
est: 150.20M (+14.8%)
239.54M
est: 228.91M (+4.6%)
262.18M
est: 261.19M (+0.4%)
281.49M
est: 277.69M (+1.4%)
322.82M
est: 320.13M (+0.8%)
373.99M
est: 371.78M (+0.6%)
327.81M
est: 536.43M (-38.9%)
153.19M
est: 152.41M (+0.5%)
505.30M
est: 207.95M (+143.0%)
612.34M
est: 684.00M (-10.5%)
791.47M
est: 1.11B (-28.5%)
229.34M
est: 995.54M (-77.0%)
866.68M
795.65M – 937.71M
-12.9% YoY
935.31M
884.37M – 986.26M
+7.9% YoY
1.07B
892.53M – 1.25B
+14.8% YoY
1.20B
1.19B – 1.22B
+12.2% YoY
1.38B
1.36B – 1.39B
+14.2% YoY
SGA
18.00M
est: 10.10M (+78.2%)
27.35M
est: 31.41M (-12.9%)
36.31M
est: 42.17M (-13.9%)
48.95M
est: 55.54M (-11.9%)
71.12M
est: 78.33M (-9.2%)
88.81M
est: 92.68M (-4.2%)
136.57M
est: 125.60M (+8.7%)
187.99M
est: 179.48M (+4.7%)
248.78M
est: 234.44M (+6.1%)
230.91M
est: 209.67M (+10.1%)
232.69M
est: 237.58M (-2.1%)
255.86M
est: 280.52M (-8.8%)
280.78M
est: 276.48M (+1.6%)
313.93M
est: 277.22M (+13.2%)
336.46M
est: 293.12M (+14.8%)
326.79M
est: 311.97M (+4.7%)
325.73M
est: 324.31M (+0.4%)
323.74M
est: 319.45M (+1.3%)
325.79M
est: 323.11M (+0.8%)
336.75M
est: 334.72M (+0.6%)
341.69M
est: 286.29M (+19.4%)
585.33M
est: 601.32M (-2.7%)
778.75M
est: 815.10M (-4.5%)
776.36M
est: 809.02M (-4.0%)
728.35M
est: 803.88M (-9.4%)
780.14M
est: 780.14M (0.0%)
778.64M
770.87M – 782.53M
-0.2% YoY
796.38M
791.50M – 801.25M
+2.3% YoY
833.19M
832.47M – 833.91M
+4.6% YoY
877.91M
868.97M – 886.94M
+5.4% YoY
920.25M
910.89M – 929.72M
+4.8% YoY
EPS
0.36
est: 0.11 (+227.3%)
0.27
est: 0.21 (+28.6%)
0.97
est: 0.26 (+273.1%)
1.22
est: 0.30 (+306.7%)
1.55
est: 0.39 (+297.4%)
1.94
est: 0.46 (+321.7%)
1.35
est: 0.57 (+136.8%)
1.95
est: 0.84 (+132.1%)
1.34
est: 1.15 (+16.5%)
1.61
est: 1.27 (+26.8%)
1.46
est: 1.50 (-2.7%)
0.38
est: 0.56 (-32.1%)
0.92
est: 0.95 (-3.2%)
1.69
est: 1.39 (+21.6%)
2.80
est: 2.21 (+26.7%)
4.08
est: 3.96 (+3.0%)
4.75
est: 4.72 (+0.6%)
5.20
est: 5.35 (-2.9%)
5.96
est: 6.07 (-1.8%)
6.85
est: 6.89 (-0.6%)
6.29
est: 6.46 (-2.6%)
2.28
est: 9.68 (-76.4%)
6.20
est: 11.69 (-47.0%)
7.46
est: 8.66 (-13.9%)
9.60
est: 13.99 (-31.4%)
2.92
est: 12.88 (-77.3%)
10.55
10.08 – 11.87
-18.1% YoY
11.73
11.20 – 12.49
+11.2% YoY
13.24
11.30 – 15.88
+12.8% YoY
15.25
15.05 – 15.46
+15.2% YoY
17.43
17.19 – 17.66
+14.2% YoY
Recent Grade Changes (3M)
Date Firm Previous New Grade Action
2026-05-18 JP Morgan Neutral Neutral Maintain
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-28 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-27 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-26 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-22 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-21 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-20 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-19 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-18 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-15 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-14 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-13 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-12 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-11 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-08 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-07 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-06 B+ 3/5 4/5 3/5 4/5 2/5 2/5 4/5
2026-05-05 A- 4/5 4/5 3/5 4/5 2/5 3/5 4/5
2026-05-04 A- 4/5 4/5 3/5 4/5 2/5 3/5 4/5
2026-05-01 B+ 3/5 4/5 3/5 4/5 1/5 3/5 4/5
2026-04-30 B+ 3/5 4/5 3/5 4/5 1/5 3/5 4/5
2026-04-29 B+ 3/5 4/5 3/5 4/5 1/5 3/5 4/5
2026-04-28 B+ 3/5 4/5 3/5 4/5 1/5 3/5 4/5
2026-04-27 B+ 3/5 4/5 3/5 4/5 1/5 3/5 4/5
2026-04-24 B+ 3/5 4/5 3/5 4/5 1/5 3/5 4/5
2026-04-23 A- 4/5 4/5 3/5 5/5 1/5 3/5 4/5
2026-04-22 A- 4/5 4/5 3/5 5/5 1/5 3/5 4/5
2026-04-21 B+ 3/5 4/5 3/5 5/5 1/5 2/5 4/5
2026-04-20 B+ 3/5 4/5 3/5 5/5 1/5 2/5 4/5
2026-04-17 B+ 3/5 4/5 3/5 5/5 1/5 2/5 4/5
2026-04-16 B+ 3/5 4/5 3/5 5/5 1/5 2/5 4/5
2026-04-15 B+ 3/5 4/5 3/5 5/5 1/5 2/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
981.20M
OE per share TTM
12.21
Owner's Yield
9.27%
Maintenance CapEx ratio
2,365.66%
Maint CapEx / Avg PPE
7.1%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
204
Total invested
1.95B
Insider transactions (90d)
3
Beneficial owners (>5%)
26
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Andrew A. Ziegler 8.22M 13.70% 7.65M 8.22M IN U.S.A. 2013-02-07
2 Artisan Investment Corporation 8.22M 13.70% 7.65M 8.22M HC U.S.A. 2013-02-07
3 Artisan Investments GP LLC 8.22M 13.70% 7.65M 8.22M HC U.S.A. 2013-02-07
4 Artisan Partners Holdings LP 8.22M 13.70% 7.65M 8.22M HC U.S.A. 2013-02-07
5 Artisan Partners Limited Partnership 8.22M 13.70% 7.65M 8.22M IA U.S.A. 2013-02-07
6 Carlene M. Ziegler 8.22M 13.70% 7.65M 8.22M IN U.S.A. 2013-02-07
7 ZFIC, Inc. 8.22M 13.70% 7.65M 8.22M HC U.S.A. 2013-02-07
8 04-2747644 7.23M 8.90% 7.01M 7.23M IA Delaware 2022-02-02
9 WCM Investment Management 5.27M 9.68% 20.3K IA Citizenship or Place of Organization 2019-02-14
10 Artisan Partners Funds, Inc. 5.22M 8.70% 5.22M 5.22M IC U.S.A. 2013-02-07
11 Wellington Group Holdings LLP 5.15M 6.33% 4.77M HC Massachusetts 2022-02-04
12 Wellington Investment Advisors Holdings LLP 5.15M 6.33% 4.77M HC Massachusetts 2022-02-04
13 Wellington Management Group LLP 5.15M 6.33% 4.77M HC Massachusetts 2022-02-04
14 Wellington Management Company LLP 4.49M 5.51% 4.33M IA Massachusetts 2022-02-04
15 George S. Loening 2.93M 5.01% 2.93M 2.93M IN USA 2009-02-17
16 13-4064930 2.56M 4.70% 2.14M 2.54M IA Delaware 2018-02-13
17 Select Equity Group, Inc. 2.07M 3.54% 2.07M 2.07M IA New York 2009-02-17
18 Neuberger Berman Group LLC 1.87M 3.41% 1.87M 1.87M HC Delaware 2017-02-14
19 Neuberger Berman Investment Advisers LLC 1.87M 3.41% 1.87M 1.87M IA Delaware 2017-02-14
20 Dr. John Climax 1.57M 11.00% 1.57M 1.57M IN Republic of Ireland 2005-10-11
21 Identification Nos. of above persons (. n/a 1.49M 10.70% 1.49M 1.49M IN of Ireland 2005-12-09
22 Neuberger Berman Equity Funds 1.40M 2.54% 1.40M 1.40M IV Delaware 2017-02-14
23 1.11M 8.20% 1.11M 1.11M IN Republic of Ireland 2004-05-27
24 Dr. Ronan Lambe 1.02M 11.00% 1.02M 1.02M IN Republic of Ireland 2005-10-11
25 Identification Nos. of above persons (: n/a 951.5K 6.80% 951.5K 951.5K IN of Ireland 2005-12-09
26 Select Offshore Advisors, LLC 856.1K 1.47% 856.1K 856.1K IA New York 2009-02-17

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
204
-314 vs prev Q
New positions
20
Closed positions
327
Increased
90
Reduced
72
Put/Call ratio
0.29
Calls held
6.5K
Puts held
1.9K
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 MACQUARIE MANAGEMENT HOLDINGS, INC. 270.1K +270.1K (+100.0%) 49.21B +49.2B (+100.0%) 0.35% +0.349 pp 0.07% +0.074 pp USD182.22 +0.0% 1 qtrs NEW
2 ARTISAN PARTNERS LIMITED PARTNERSHIP 6.87M -197.4K (-2.8%) 1.25B +15.1M (+1.2%) 8.88% -0.039 pp 1.88% +0.120 pp USD164.04 +11.1% 5 qtrs
3 WELLINGTON MANAGEMENT GROUP LLP 4.35M -286.4K (-6.2%) 792.79M -18.7M (-2.3%) 5.62% -0.229 pp 0.14% -0.003 pp USD186.11 -2.1% 52 qtrs
4 ORBIS ALLAN GRAY LTD 4.21M +75.8K (+1.8%) 768.00M +43.7M (+6.0%) 5.45% +0.224 pp 3.22% +0.109 pp USD172.78 +5.5% 7 qtrs
5 INVESCO LTD. 3.76M +329.3K (+9.6%) 684.58M +84.7M (+14.1%) 4.86% +0.530 pp 0.11% +0.011 pp USD189.51 -3.8% 51 qtrs
6 FMR LLC 3.10M +1.2M (+60.2%) 564.50M +226.2M (+66.9%) 4.00% +1.564 pp 0.03% +0.011 pp USD213.50 -14.7% 39 qtrs
7 PRINCIPAL FINANCIAL GROUP INC 3.00M -275.8K (-8.4%) 546.94M -26.6M (-4.6%) 3.88% -0.256 pp 0.28% -0.010 pp USD172.89 +5.4% 44 qtrs
8 FRANKLIN RESOURCES INC 2.99M +239.8K (+8.7%) 545.41M +63.7M (+13.2%) 3.87% +0.394 pp 0.13% +0.014 pp USD200.15 -9.0% 22 qtrs
9 NINETY ONE UK LTD 2.95M -60.3K (-2.0%) 536.79M +10.7M (+2.0%) 3.81% +0.014 pp 1.15% +0.015 pp USD207.49 -12.2% 25 qtrs
10 HARRIS ASSOCIATES L P 2.51M +167.6K (+7.2%) 457.40M +47.5M (+11.6%) 3.24% +0.288 pp 0.58% -0.079 pp USD156.20 +16.7% 3 qtrs
11 MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.36M -1.1M (-32.7%) 429.50M -183.6M (-29.9%) 3.05% -1.375 pp 0.14% -0.051 pp USD189.34 -3.8% 34 qtrs
12 RUANE, CUNNIFF & GOLDFARB L.P. 1.68M -21.4K (-1.3%) 306.05M +8.4M (+2.8%) 2.17% +0.024 pp 4.78% -0.152 pp USD192.64 -5.4% 5 qtrs
13 CAPITAL WORLD INVESTORS 1.50M +1.3M (+555.2%) 272.69M +232.7M (+582.3%) 1.93% +1.646 pp 0.04% +0.032 pp USD181.12 +0.6% 2 qtrs
14 1.40M +118.0K (+9.2%) 254.38M +30.7M (+13.7%) 1.80% +0.192 pp 19.01% +2.324 pp USD165.82 +9.9% 4 qtrs
15 ALLIANCEBERNSTEIN L.P. 1.27M -101.6K (-7.4%) 231.87M -8.6M (-3.6%) 1.64% -0.089 pp 0.07% -0.003 pp USD185.07 -1.5% 52 qtrs
16 BOSTON PARTNERS 1.26M +519.8K (+70.3%) 229.40M +100.0M (+77.3%) 1.63% +0.694 pp 0.24% +0.105 pp USD179.13 +1.7% 52 qtrs
17 1832 ASSET MANAGEMENT L.P. 1.20M +202.0 (+0.0%) 219.45M +8.7M (+4.1%) 1.56% +0.037 pp 0.17% +0.001 pp USD155.49 +17.2% 11 qtrs
18 ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 1.08M +11.3K (+1.1%) 203.80M -1.8M (-0.9%) 1.40% +0.047 pp 0.33% +0.000 pp USD194.33 -6.2% 15 qtrs
19 TRINITY STREET ASSET MANAGEMENT LLP 1.07M +201.5K (+23.1%) 195.42M +43.0M (+28.2%) 1.39% +0.287 pp 12.28% +1.891 pp USD221.20 -17.6% 19 qtrs
20 AMERICAN CENTURY COMPANIES INC 1.04M +610.7K (+142.9%) 189.15M +114.4M (+152.9%) 1.34% +0.802 pp 0.10% +0.057 pp USD192.66 -5.4% 29 qtrs
21 FIRST PACIFIC ADVISORS, LP 980.8K +6.5K (+0.7%) 178.72M +8.2M (+4.8%) 1.27% +0.038 pp 2.35% -0.004 pp USD172.30 +5.8% 14 qtrs
22 LYRICAL ASSET MANAGEMENT LP 968.0K +968.0K (+100.0%) 176.38M +176.4M (+100.0%) 1.25% +1.251 pp 2.31% +2.307 pp USD182.22 +0.0% 1 qtrs NEW
23 EARNEST PARTNERS LLC 890.1K +80.4K (+9.9%) 162.19M +20.5M (+14.5%) 1.15% +0.129 pp 0.70% +0.080 pp USD122.49 +48.8% 51 qtrs
24 NORGES BANK 878.5K +878.5K (+100.0%) 160.07M +160.1M (+100.0%) 1.14% +1.135 pp 0.02% +0.017 pp USD182.22 +0.0% 1 qtrs NEW
25 SEI INVESTMENTS CO 785.9K +86.7K (+12.4%) 143.21M +20.8M (+17.0%) 1.02% +0.133 pp 0.14% +0.010 pp USD174.62 +4.4% 45 qtrs
26 BRANDES INVESTMENT PARTNERS, LP 776.7K +21.1K (+2.8%) 141.54M +9.3M (+7.0%) 1.00% +0.050 pp 1.08% +0.017 pp USD167.30 +8.9% 3 qtrs
27 JPMORGAN CHASE & CO 767.9K +629.1K (+453.0%) 139.93M +115.6M (+475.8%) 0.99% +0.817 pp 0.01% +0.007 pp USD197.31 -7.6% 45 qtrs
28 VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. 743.5K +743.5K (+100.0%) 135.49M +135.5M (+100.0%) 0.96% +0.961 pp 1.16% +1.160 pp USD182.22 +0.0% 1 qtrs NEW
29 JENNISON ASSOCIATES LLC 678.0K +678.0K (+100.0%) 123.54M +123.5M (+100.0%) 0.88% +0.876 pp 0.07% +0.074 pp USD182.22 +0.0% 1 qtrs NEW
30 D. E. SHAW & CO., INC. 653.3K -823.8K (-55.8%) 119.05M -139.4M (-53.9%) 0.84% -1.020 pp 0.07% -0.081 pp USD187.49 -2.8% 9 qtrs
31 EQUITY INVESTMENT CORP 623.2K -5.0K (-0.8%) 113.56M +3.6M (+3.3%) 0.81% +0.013 pp 2.29% -0.011 pp USD148.40 +22.8% 3 qtrs
32 CLEARBRIDGE INVESTMENTS, LLC 617.0K -517.4K (-45.6%) 112.43M -86.1M (-43.4%) 0.80% -0.634 pp 0.09% -0.060 pp USD194.11 -6.1% 52 qtrs
33 BANK OF AMERICA CORP /DE/ 609.7K +64.4K (+11.8%) 111.09M +15.7M (+16.4%) 0.79% +0.100 pp 0.01% +0.002 pp USD211.89 -14.0% 52 qtrs
34 STEPHENS INVESTMENT MANAGEMENT GROUP LLC 543.0K +62.9K (+13.1%) 98.94M +14.9M (+17.8%) 0.70% +0.096 pp 1.29% +0.199 pp USD125.35 +45.4% 52 qtrs
35 UBS GROUP AG 538.6K +88.1K (+19.5%) 98.15M +19.3M (+24.5%) 0.70% +0.128 pp 0.02% +0.004 pp USD175.12 +4.1% 45 qtrs
36 BAMCO INC /NY/ 534.2K -150.7K (-22.0%) 97.35M -22.5M (-18.8%) 0.69% -0.174 pp 0.26% -0.054 pp USD118.21 +54.1% 52 qtrs
37 DIMENSIONAL FUND ADVISORS LP 523.0K +101.7K (+24.1%) 95.30M +21.6M (+29.3%) 0.68% +0.144 pp 0.02% +0.004 pp USD234.19 -22.2% 18 qtrs
38 FISHER FUNDS MANAGEMENT LTD 513.1K +82.0K (+19.0%) 93.21M +17.8M (+23.6%) 0.66% +0.119 pp 2.41% +0.414 pp USD202.31 -9.9% 5 qtrs
39 ALTRINSIC GLOBAL ADVISORS LLC 507.8K +204.4K (+67.4%) 92.54M +39.4M (+74.3%) 0.66% +0.274 pp 3.32% +1.354 pp USD177.91 +2.4% 2 qtrs
40 FIDUCIARY MANAGEMENT INC /WI/ 481.0K -79.9K (-14.3%) 87.65M -10.5M (-10.7%) 0.62% -0.086 pp 0.96% -0.029 pp USD188.26 -3.2% 5 qtrs
41 RIVER ROAD ASSET MANAGEMENT, LLC 475.4K +169.9K (+55.6%) 86.63M +33.2M (+62.0%) 0.61% +0.229 pp 0.95% +0.351 pp USD164.58 +10.7% 3 qtrs
42 MORGAN STANLEY 473.6K -26.7K (-5.3%) 86.31M -1.3M (-1.4%) 0.61% -0.019 pp 0.01% 0.000 pp USD211.40 -13.8% 51 qtrs
43 GOLDMAN SACHS GROUP INC 473.2K +24.4K (+5.4%) 86.22M +7.7M (+9.8%) 0.61% +0.045 pp 0.01% +0.001 pp USD228.73 -20.3% 52 qtrs
44 NINETY ONE NORTH AMERICA, INC. 455.4K +12.6K (+2.8%) 82.98M +5.5M (+7.1%) 0.59% +0.030 pp 3.36% -0.149 pp USD204.51 -10.9% 25 qtrs
45 VOYA INVESTMENT MANAGEMENT LLC 438.3K +436.1K (+19,424.2%) 79.87M +79.5M (+20,229.8%) 0.57% +0.564 pp 0.08% +0.078 pp USD182.18 +0.0% 2 qtrs
46 BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC 399.8K +22.4K (+5.9%) 71.68M +10.8M (+17.8%) 0.52% +0.041 pp 0.48% +0.063 pp USD159.11 +14.5% 4 qtrs
47 BLACKROCK, INC. 377.8K +123.8K (+48.7%) 68.85M +24.4M (+54.9%) 0.49% +0.168 pp 0.00% +0.000 pp USD236.23 -22.9% 6 qtrs
48 LAZARD ASSET MANAGEMENT LLC 372.4K -233.1K (-38.5%) 67.87M -38.1M (-36.0%) 0.48% -0.283 pp 0.12% -0.028 pp USD216.18 -15.7% 34 qtrs
49 STATE STREET CORP 361.2K +2.3K (+0.6%) 65.82M +3.0M (+4.8%) 0.47% +0.014 pp 0.00% +0.000 pp USD227.43 -19.9% 49 qtrs
50 SAMLYN CAPITAL, LLC 337.7K +337.7K (+100.0%) 61.53M +61.5M (+100.0%) 0.44% +0.436 pp 0.98% +0.980 pp USD182.22 +0.0% 1 qtrs NEW
51 LAKEWOOD CAPITAL MANAGEMENT, LP 332.5K +93.3K (+39.0%) 60.59M +18.7M (+44.7%) 0.43% +0.128 pp 4.01% +0.851 pp USD159.68 +14.1% 3 qtrs
52 BROWN BROTHERS HARRIMAN & CO 289.4K -79.2K (-21.5%) 52.74M -11.8M (-18.2%) 0.37% -0.091 pp 0.29% -0.105 pp USD221.57 -17.8% 30 qtrs
53 QUBE RESEARCH & TECHNOLOGIES LTD 289.1K -269.7K (-48.3%) 52.69M -45.1M (-46.1%) 0.37% -0.332 pp 0.05% -0.048 pp USD198.75 -8.3% 9 qtrs
54 THRIVENT FINANCIAL FOR LUTHERANS 283.5K +283.5K (+100.0%) 51.66M +51.7M (+100.0%) 0.37% +0.366 pp 0.09% +0.092 pp USD182.22 +0.0% 1 qtrs NEW
55 RUSSELL INVESTMENTS GROUP, LTD. 280.9K +35.3K (+14.4%) 51.19M +8.2M (+19.1%) 0.36% +0.053 pp 0.06% +0.007 pp USD178.44 +2.1% 37 qtrs
56 HGK ASSET MANAGEMENT INC 260.4K +59.7K (+29.7%) 47.46M +12.3M (+35.1%) 0.34% +0.083 pp 7.03% +1.345 pp USD249.98 -27.1% 9 qtrs
57 JANUS HENDERSON GROUP PLC 248.3K +28.0K (+12.7%) 45.24M +6.7M (+17.4%) 0.32% +0.043 pp 0.02% +0.003 pp USD241.00 -24.4% 52 qtrs
58 EAGLE HEALTH INVESTMENTS LP 247.1K +64.5K (+35.3%) 45.02M +13.1M (+40.9%) 0.32% +0.089 pp 9.89% +1.506 pp USD201.17 -9.4% 13 qtrs
59 NEW YORK STATE COMMON RETIREMENT FUND 246.4K +21.6K (+9.6%) 44.89M +5.6M (+14.1%) 0.32% +0.035 pp 0.06% +0.009 pp USD175.23 +4.0% 51 qtrs
60 MANUFACTURERS LIFE INSURANCE COMPANY, THE 242.5K +30.9K (+14.6%) 44.19M +7.2M (+19.3%) 0.31% +0.046 pp 0.04% +0.006 pp USD182.20 +0.0% 18 qtrs
61 DIAMOND HILL CAPITAL MANAGEMENT INC 239.1K +4.7K (+2.0%) 43.58M +2.5M (+6.2%) 0.31% +0.013 pp 0.22% +0.029 pp USD206.26 -11.7% 12 qtrs
62 ILEX CAPITAL PARTNERS (UK) LLP 211.9K +211.9K (+100.0%) 38.61M +38.6M (+100.0%) 0.27% +0.274 pp 1.09% +1.090 pp USD182.22 +0.0% 1 qtrs NEW
63 CIBC PRIVATE WEALTH GROUP, LLC 205.3K -18.5K (-8.3%) 37.41M -1.8M (-4.5%) 0.27% -0.017 pp 0.06% -0.004 pp USD206.30 -11.7% 34 qtrs
64 POINT72 ASSET MANAGEMENT, L.P. 194.2K -267.9K (-58.0%) 35.38M -45.5M (-56.2%) 0.25% -0.332 pp 0.04% -0.096 pp USD153.84 +18.4% 19 qtrs
65 CANOE FINANCIAL LP 193.9K -4.1K (-2.0%) 35.34M +690.8K (+2.0%) 0.25% +0.001 pp 0.48% -0.015 pp USD197.52 -7.7% 5 qtrs
66 RAYMOND JAMES FINANCIAL INC 191.1K -33.3K (-14.8%) 34.82M -4.4M (-11.3%) 0.25% -0.036 pp 0.01% -0.002 pp USD193.86 -6.0% 5 qtrs
67 SUSQUEHANNA INTERNATIONAL GROUP, LLP 190.4K +118.1K (+163.3%) 34.69M +22.0M (+174.2%) 0.25% +0.155 pp 0.00% +0.003 pp USD187.58 -2.9% 50 qtrs
68 AMERIPRISE FINANCIAL INC 184.1K +11.7K (+6.8%) 33.55M +3.4M (+11.2%) 0.24% +0.020 pp 0.01% +0.001 pp USD231.90 -21.4% 51 qtrs
69 CANADA PENSION PLAN INVESTMENT BOARD 176.7K +42.7K (+31.8%) 32.21M +8.7M (+37.3%) 0.23% +0.059 pp 0.02% +0.005 pp USD216.43 -15.8% 50 qtrs
70 HOLOCENE ADVISORS, LP 162.0K -230.5K (-58.7%) 29.52M -39.2M (-57.0%) 0.21% -0.286 pp 0.06% -0.095 pp USD158.41 +15.0% 13 qtrs
71 NEUBERGER BERMAN GROUP LLC 160.8K -18.3K (-10.2%) 29.31M -1.9M (-6.2%) 0.21% -0.018 pp 0.02% -0.001 pp USD92.86 +96.2% 51 qtrs
72 CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 156.1K -981.0 (-0.6%) 28.44M +955.0K (+3.5%) 0.20% +0.004 pp 0.02% 0.000 pp USD161.26 +13.0% 52 qtrs
73 ZUCKERMAN INVESTMENT GROUP, LLC 155.6K +3.9K (+2.6%) 28.36M +1.8M (+6.8%) 0.20% +0.010 pp 2.53% +0.074 pp USD189.73 -4.0% 5 qtrs
74 LEGAL & GENERAL GROUP PLC 147.7K +10.6K (+7.7%) 26.92M +2.9M (+12.2%) 0.19% +0.018 pp 0.01% +0.001 pp USD223.68 -18.5% 37 qtrs
75 PHILOSOPHY CAPITAL MANAGEMENT LLC 144.1K +64.4K (+80.9%) 26.25M +12.3M (+88.4%) 0.19% +0.086 pp 1.19% +0.624 pp USD178.23 +2.2% 2 qtrs
76 WALLEYE CAPITAL LLC 134.3K +45.2K (+50.7%) 24.47M +8.9M (+56.9%) 0.17% +0.061 pp 0.08% +0.017 pp USD178.24 +2.2% 9 qtrs
77 SIO CAPITAL MANAGEMENT, LLC 127.2K +127.2K (+100.0%) 23.18M +23.2M (+100.0%) 0.16% +0.164 pp 3.65% +3.646 pp USD182.22 +0.0% 1 qtrs NEW
78 BROWN CAPITAL MANAGEMENT LLC 124.6K -45.7K (-26.8%) 22.71M -7.1M (-23.8%) 0.16% -0.054 pp 1.86% +0.634 pp USD80.21 +127.2% 52 qtrs
79 PFM HEALTH SCIENCES, LP 115.3K -18.3K (-13.7%) 21.02M -2.4M (-10.2%) 0.15% -0.020 pp 2.10% +0.297 pp USD185.03 -1.5% 27 qtrs
80 ENVESTNET ASSET MANAGEMENT INC 115.1K -35.9K (-23.8%) 20.98M -5.5M (-20.6%) 0.15% -0.042 pp 0.01% -0.001 pp USD225.89 -19.3% 51 qtrs
81 HUDSON BAY CAPITAL MANAGEMENT LP 114.0K +— (+0.0%) 20.77M +823.1K (+4.1%) 0.15% +0.004 pp 0.07% +0.002 pp USD145.45 +25.3% 3 qtrs
82 PROSIGHT MANAGEMENT, LP 110.0K +500.0 (+0.5%) 20.04M +881.7K (+4.6%) 0.14% +0.004 pp 4.14% -0.327 pp USD183.67 -0.8% 5 qtrs
83 AVIVA PLC 109.1K -1.5K (-1.4%) 19.88M +525.7K (+2.7%) 0.14% +0.001 pp 0.03% -0.002 pp USD176.96 +3.0% 16 qtrs
84 POLEN CAPITAL MANAGEMENT LLC 105.2K -338.3K (-76.3%) 19.17M -58.4M (-75.3%) 0.14% -0.424 pp 0.08% -0.170 pp USD213.40 -14.6% 35 qtrs
85 WELLS FARGO & COMPANY/MN 104.6K -43.1K (-29.2%) 19.05M -6.8M (-26.2%) 0.14% -0.051 pp 0.00% -0.001 pp USD197.10 -7.5% 52 qtrs
86 EVERSEPT PARTNERS, LP 95.8K +40.8K (+74.2%) 17.46M +7.8M (+81.3%) 0.12% +0.054 pp 0.88% +0.216 pp USD167.15 +9.0% 18 qtrs
87 PERRY CREEK CAPITAL LP 95.0K +— (+0.0%) 17.31M +685.9K (+4.1%) 0.12% +0.003 pp 10.39% +0.767 pp USD175.00 +4.1% 2 qtrs
88 BROWN ADVISORY INC 92.4K +3.7K (+4.2%) 16.83M +1.3M (+8.5%) 0.12% +0.008 pp 0.02% +0.003 pp USD172.57 +5.6% 6 qtrs
89 GEODE CAPITAL MANAGEMENT, LLC 91.7K -2.0K (-2.2%) 16.70M +304.0K (+1.9%) 0.12% +0.000 pp 0.00% +0.000 pp USD234.71 -22.4% 52 qtrs
90 ROYAL BANK OF CANADA 91.5K -90.2K (-49.7%) 16.67M -15.1M (-47.6%) 0.12% -0.111 pp 0.00% -0.003 pp USD177.89 +2.4% 51 qtrs
91 VANGUARD GROUP INC 91.5K +2.9K (+3.3%) 16.67M +1.2M (+7.6%) 0.12% +0.007 pp 0.00% +0.000 pp USD229.53 -20.6% 48 qtrs
92 RUNNING OAK CAPITAL LLC 91.5K -6.9K (-7.0%) 16.67M -540.6K (-3.1%) 0.12% -0.006 pp 2.09% +0.159 pp USD190.07 -4.1% 14 qtrs
93 STATE OF MICHIGAN RETIREMENT SYSTEM 85.1K +— (+0.0%) 15.50M +614.2K (+4.1%) 0.11% +0.003 pp 0.08% +0.004 pp USD224.76 -18.9% 21 qtrs
94 FARMERS & MERCHANTS INVESTMENTS INC 80.6K +537.0 (+0.7%) 14.68M +675.7K (+4.8%) 0.10% +0.003 pp 0.41% +0.009 pp USD154.02 +18.3% 47 qtrs
95 PARTHENON LLC 79.2K -582.0 (-0.7%) 14.43M +470.0K (+3.4%) 0.10% +0.002 pp 1.56% +0.010 pp USD152.05 +19.8% 3 qtrs
96 FORESIGHT GROUP LTD LIABILITY PARTNERSHIP 80.9K -858.0 (-1.0%) 14.43M +123.2K (+0.9%) 0.10% +0.001 pp 2.17% +0.036 pp USD176.15 +3.4% 5 qtrs
97 BALYASNY ASSET MANAGEMENT L.P. 75.5K +75.5K (+100.0%) 13.76M +13.8M (+100.0%) 0.10% +0.098 pp 0.02% +0.018 pp USD182.22 +0.0% 19 qtrs
98 HOUND PARTNERS, LLC 75.0K +— (+0.0%) 13.67M +541.5K (+4.1%) 0.10% +0.002 pp 1.84% +0.153 pp USD145.45 +25.3% 3 qtrs
99 CAMBIAR INVESTORS LLC 74.8K -4.2K (-5.3%) 13.63M -196.2K (-1.4%) 0.10% -0.003 pp 0.61% -0.020 pp USD194.84 -6.5% 5 qtrs
100 MUHLENKAMP & CO INC 73.9K +398.0 (+0.5%) 13.46M +603.0K (+4.7%) 0.10% +0.003 pp 3.62% +0.125 pp USD175.04 +4.1% 2 qtrs
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
1.00
Neutral
Buys
3
Sells
3
Shares acquired
13.3K
Shares disposed
13.3K
Cash buys
Cash sales
Net activity
+0
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-05-14 Murphy Ronan Martin Director A-Award A Stock Options 5,005 125.74 629.3K 5,005 D
2026-05-14 McCague Eugene Pacelli Director A-Award A Stock Options 3,255 125.74 409.3K 3,255 D
2026-05-14 CLIMAX JOHN DR Director A-Award A Stock Options 5,005 125.74 629.3K 5,005 D
2026-03-18 Whitaker Anne Clem Director Restricted Share Units 1,732 0.00 0 D
2026-03-18 O'Neill Julie Director Restricted Share Units 1,732 0.00 0 D
2026-03-18 Murray Ciaran Director Restricted Share Units 2,677 0.00 0 D
2026-03-18 Murphy Ronan Martin Director Restricted Share Units 1,732 0.00 0 D
2026-03-18 McCague Eugene Pacelli Director Stock Options 3,255 125.74 409.3K 0 D
2026-03-18 Lyons Emer Officer Restricted Share Units 2,306 0.00 0 D
2026-03-18 Grais Linda Director Restricted Share Units 1,732 0.00 0 D
2026-03-18 Cutler Stephen A Director Stock Options 32,272 140.38 4.53M 0 D
2026-03-18 Clerkin Nigel Bernard John Officer Restricted Share Units 2,755 0.00 0 D
2026-03-18 CLIMAX JOHN DR Director Restricted Share Units 1,732 0.00 0 D
2026-03-18 Balfe Barry Edward Director / Officer Stock Options 4,914 325.51 1.60M 0 D

Executive team

Top executives
EBIT / Employee
10.8K
Shares Outstanding
76.36M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-27 6-K/A
2026-05-27 6-K
2026-05-27 20-F
2026-05-26 6-K
2026-05-15 SC 13G/A
2026-05-15 SC 13G/A
2026-05-15 SC 13G
2026-05-15 4
2026-05-15 4
2026-05-15 4

Executive team

NameTitleCompensationGender
Barry Balfe Chief Executive Officer & Director 2M male
Nigel Clerkin Chief Financial Officer 762.0K male
John Climax Founder & Independent Non-Executive Director 98.0K
Gary Curtis Senior Vice President of Global Clinical Pharmacology
Joe Cronin Chief Human Resources Officer male
Diarmaid Cunningham Chief Administrative Officer, General Counsel & Company Secretary male
Lyons Emer Chief Accounting Officer
Niamh Murphy Director of Corporate Communications female
David Green Vice President of Marketing male
Simon Holmes President of Corporate Investments & Partnerships male
Thomas N. O'Leary Chief Information Officer male
ESG Rating
B
MEDICAL - DIAGNOSTICS & RESEARCH
Rank: 8 out of 58
2025
E (Environmental)
52.3 / 61.3
Company / Sector avg.
S (Social)
72.4 / 65.4
Company / Sector avg.
G (Governance)
61.2 / 64.9
Company / Sector avg.
ESG Total
62.0 / 63.8
Company / Sector avg.
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity
Transaction Date Disclosed Representative District Owner Type Amount Link
2026-03-05 2026-04-06 Kevin Hern OK01 Sale $100,001 - $250,000
2026-02-12 2026-03-13 Julia Letlow Sale $1,001 - $15,000
2024-09-04 2024-09-06 John James MI10 Sale (Full) $1,001 - $15,000
2024-06-12 2024-09-02 John James MI10 Purchase $1,001 - $15,000
2023-01-31 2023-02-14 Kevin Hern OK01 Joint Sale (Full) $1,001 - $15,000
2021-05-18 2021-06-15 Kevin Hern OK01 Joint Purchase $100,001 - $250,000
2020-07-27 2020-08-15 Kevin Hern OK01 Joint Purchase $1,001 - $15,000
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits